Extracellular matrix ligands promote RPE attachment to inner Bruch's membrane

Current Eye Research

Volumn 25, Issue 2, 2002, Pages 79-89

  Del Priore, Lucian V ^a   Geng, Lee ^a   Tezel, Tongalp H ^b   Kaplan, Henry J ^b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bruch's membrane; Cell adhesion; Extracellular matrix; Retinal pigment epithelium; RPE transplantation

Indexed keywords

COLLAGEN TYPE 4; ELASTIN; FIBRONECTIN; LAMININ; LIGAND; VITRONECTIN;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BRUCH MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; EXPLANT; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; MATERIAL COATING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TEMPERATURE;

ADULT; AGED; BRUCH MEMBRANE; CELL ADHESION; CELLS, CULTURED; COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HUMANS; LAMININ; LIGANDS; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; VITRONECTIN;

EID: 0036959652     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.25.2.79.10158     Document Type: Article

References (58)

1. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32:375-413.
2. Gass JDM. Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment. 3rd ed. St. Louis: C.V. Mossy Company, 1987.
3. Bressler SB, Bressler NM, Fine SL et al. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol. 1982;93:157-163.
4. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: Results of a randomized clinical trial. Arch Ophthalmol. 1991;109:1220-1231.
5. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: Results of a randomized clinical trial. Arch Ophthalmol. 1991;109:1232-1241.
6. TAP Study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials: TAP report. Arch Ophthalmol. 1999;117:1329-1345.
7. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes. Ophthalmol. 1992;99:969-976.
8. Lambert HM, Capone A, Jr., Aaberg TM, Sternberg P, Jr., Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;113:257-262.
9. Thomas MA, Grand MG, Williams DF et al. Surgical management of subfoveal choroidal neovascularization. Ophthalmol. 1992;99:952-968.
10. Submacular Surgery Trials Pilot Study Investigators. Submacular surgery trials pilot trial of laser photocoagulation versus submacular surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes. Am J Ophthalmol. 2000;130:387-407.
11. De Juan E, Jr., Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. 1989;105:25-29.
12. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular translocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol. 1993;231:635-641.
13. Ninomiya Y, Lewis JM, Hasegawa T, Tano Y. Retinotomy and foveal translocation for surgical management of sub-foveal choroidal neovascular membranes. Am J Ophthalmol. 1996;122:613-621.
14. Pieramici DJ, De Juan E, Fujii GY, Reynolds SM, Melia M, Humayun M, Schachat AP, Hartranft CD. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2000;130:419-428.
15. Spaide RF, Guyer DR, McCormick B et al. External beam radiation therapy for choroidal neovascularization. Ophthalmol. 1998;105:24-30.
16. Finger PT, Chakravarthy U, Augsburger JJ. Radiotherapy and the treatment of age-related macular degeneration. External beam radiation therapy is effective in the treatment of age-related macular degeneration. Arch Ophthalmol. 1998;116:1507-1511.
17. Bergink GJ, Hoyng CB, Van der Maazen RW, Vingerling JR, Van Daal WA, Deutman AF. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: Radiation versus observation. Graefes Arch Clin Exp Ophthalmol. 1998;236:321-325.
18. Fung WE. Interferon alpha 2a for treatment of age-related macular degeneration. Am J Ophthalmol. 1991;112:349-350.
19. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 2000;20:244-250.
20. Chong NH, Bird AC. Alternative therapies in exudative age related macular degeneration. Br J Ophthalmol. 1998;82:1441-1443.
21. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefe's Arch Clin Exp Ophthalmol. 1994;232:707-716.
22. Gouras P, Algvere P. Retinal cell transplantation in the macula: New techniques. Vis Res. 1996;36:4121-4125.
23. Algvere PV, Berglin L, Gouras P, Sheng Y, Kopp ED. Transplantation of RPE in age-related macular degeneration: Observations in disciform lesions and dry RPE atrophy. Graefe's Arch Clin Exp Ophthalmol. 1997;235:149-158.
24. Kaplan HJ, Del Priore LV, Tezel TH, Berger AS. Retinal pigment epithelial transplantation for subfoveal neovascularization in age-related macular degeneration: A clinical trial. The Retina Society, Washington, D.C., September 1998.
25. Weisz JM, Humayun MS, De Juan E, Jr., Del Cerro M, Sunness JS, Dagnelie G, Soylu M, Rizzo L, Nussenblatt RB. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. Retina. 1999;19:540-545.
26. Del Priore LV, Kaplan HJ, Tezel TH, Hayashi N, Green WR. Retinal pigment epithelial cell transplantation after sub-foveal membranectomy in age-related macular degeneration: Clinicopathologic correlation. Am J Ophthalmol. 2001;131:472-480.
27. Del Priore LV, Kaplan HJ, Berger AS. Retinal pigment epithelial transplantation in the management of subfoveal choroidal neovascularization. Seminars Ophthalmol. 1997;12:45-55.
28. Kaplan HJ, Tezel TH, Del Priore LV. Retinal pigment epithelial transplantation in age-related macular degeneration [editorial]. Retina. 1998;18:99-102.
29. Del Priore LV, Tezel TH. Reattachment rate of human retinal pigment epithelium to layers of human Bruch's membrane. Arch Ophthalmol. 1998;116;335-341.
30. Tezel TH, Del Priore LV, Kaplan HJ. Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch's membrane. Invest Ophthalmol Vis Sci. 1999;40:467-476.
31. Tezel TH, Del Priore LV. Repopulation of different layers of host human Bruch's membrane by retinal pigment epithelial cell grafts. Invest Ophthalmol Vis Sci. 1999;40:767-774.
32. Davis WL, Jones RG, Hagler HK. An electron microscopic histochemical and analytical X-ray microprobe study of calcification in Bruch's membrane from human eyes. J Histochem Cytochem. 1981;29:601-608.
33. Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci. 1995;36:1290-1297.
34. Sarks SH. Aging and degeneration in the macular region: A clinico-pathological study. Br J Ophthalmol. 1976;60:324-341.
35. Spraul CW, Grossniklaus HE. Characteristics of drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol. 1997;115:267-273.
36. Van der Schaft TL, Mooy CM, De Bruijn WC, Oron FG, Mulder PGH, De Jong PTVM. Histologic features of the early stages of age-related macular degeneration: A statistical analysis. Ophthalmol. 1992;99:278-286.
37. Green WR, Enger C. Age-related macular degeneration histopathologic studies. Ophthalmol. 1993;100:1519-1535.
38. Karwatowski WS, Jeffries TE, Duance VC, Albon J, Bailey AJ, Eastly DL. Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. Br J Ophthalmol. 1995;79:944-952.
39. Karwatowski WS, Jeffries TE, Duance VC, Albon J, Bailey AJ, Eastly DL. Collagen and ageing in Bruch's membrane. Biochem Soc Trans. 1991;19:349S.
40. Grossniklaus HE, Green WR. Histopathologic and ultra-structural findings of surgically excised choroidal neovascularization. Submacular surgery trials research group. Arch Ophthalmol. 1998;116:745-749.
41. Tezel TH, Del Priore LV, Kaplan HJ. Harvest and storage of adult human retinal pigment epithelial sheets. Curr Eye Res. 1997;16:802-809.
42. Pfeffer B. Improved methodology for cell culture of human and monkey retinal pigment epithelium. Prog Retina Res. 1991;10:251-291.
43. Tezel TH, Del Priore LV. Density-dependent growth regulation of pig retinal pigment epithelial cells in vitro. Graefe's Arch Clinical and Exp Ophthalmol. 1996;234:S89-S95.
44. Ho TC, Del Priore LV. Reattachment of human retinal pigment epithelium to extracellular matrix and human Bruch's membrane. Invest Ophthalmol Vis Sci. 1997;38:1110-1118.
45. Marshall NJ, Goodwin CJ, Holt SJ. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regulation. 1995;5:69-84.
46. Haugland RP, Larison KD. Fluorescent dyes for assessing vital cell functions.Handbook of Fluorescent Probes and Research Chemicals. 5th ed. Eugene, OR: Molecular Probes; 1994:172-180.
47. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. 2nd ed. Norwalk, CT: Appleton and Lange Publications; 1994:117-119.
48. Das A, Frank RN, Zhang NL, Turczyn TJ. Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch's membrane. Arch Ophthalmol. 1990;108:421-429.
49. Geng L, Del Priore LV, Tezel TH, Kaplan HJ. Resurfacing of elastin layer and inner collagen layer of human Bruch's membrane in vitro [ARVO Abstracts number 4996]. Invest Ophthalmol Vis Sci. 2001;42;S932.
50. Korte GE, Reppucci V, Henkind P. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci. 1984;25:1135-1145.
51. Del Priore LV, Hornbeck R, Kaplan HJ et al. Debridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol. 1995;113:939-944.
52. Del Priore LV, Hornbeck R, Kaplan HJ, Jones Z, Swinn M. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol. 1996;122:629-643.
53. Leonard DS, Zhang XG, Panozzo G, Sugino IK, Zarbin MA. Clinicopathologic correlation of localized retinal pigment epithelium debridement. Invest Ophthalmol Vis Sci. 1997;38:1094-1109.
54. Miller FS, III, Bunt-Milam AH, Kalina RE. Clinical ultra-structural study of thioridazine retinopathy. Ophthalmol. 1980;89:1478-1488.
55. Henkind P, Gartner S. The relationship between retinal pigment epithelium and the choriocapillaris. Tr Ophthalmol Soc UK. 1983;103:444-447.
56. Kuwabara T, Ishikawa Y, Kaiser-Kupfer MI. Experimental model of gyrate atrophy in animals. Ophthalmol. 1981;88:331-334.
57. Takeuchi M, Itagaki T, Takahashi K, Ohkuma H, Uyama M. Changes in the intermediate stage of retinal degeneration after intravitreal injection of ornithine. Acta Societatis Ophthalmologicae Japonicae. 1993;97:17-28.
58. Nasir MA, Sugino I, Zarbin MA. Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration. Br J Ophthalmol. 1997;81:481-489.